Sign In
Buy BCS
$24.69
-0.590 (-2.33%)
At Close: Jun 03, 2026
Barclays names top 4 defensive stocks to weather global uncertainty
09:56am, Tuesday, 31'st Mar 2026
As Dow Jones slides into the “correction territory” and the benchmark S&P 500 index logs its fifth consecutive week of losses, investors are increasingly desperate for a port in the storm. Accordi
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Barclays PLC Investors to Inquire About Securities Class Action Investigation - BCS
04:15pm, Monday, 30'th Mar 2026
New York, New York--(Newsfile Corp. - March 30, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Barcla
Barclays analyst on how risk is being priced into oil markets during the U.S.-Iran war
02:15pm, Monday, 30'th Mar 2026
Amarpreet Singh, energy analyst at Barclays, joins ‘Money Movers' to discuss oil supply disruptions from the Iran war, vulnerabilities in the energy market, and more.
Rosen Law Firm Encourages Barclays PLC Investors to Inquire About Securities Class Action Investigation - BCS
04:10am, Monday, 30'th Mar 2026
NEW YORK, March 30, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Barclays PLC (NYSE:
NEW YORK, March 28, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Barclays PLC (NY
Bullish On Barclays Again, As It Stands Out Among Europe's Global Diversified Banks
06:29am, Saturday, 28'th Mar 2026
Barclays is reaffirmed as a buy, standing out for strong fundamentals, performance vs. similar banks, attractive valuation, and upside forecasts despite macro headwinds. BCS demonstrated robust top-li
Phathom Pharmaceuticals Upgraded by Barclays to Overweight With $18 Target
11:07am, Friday, 27'th Mar 2026
Barclays analyst Jenna Davidner upgraded Phathom Pharmaceuticals (NASDAQ:PHAT) to Overweight from Equal Weight on Friday, raising her price target to $18 from $16.
Germany fines Barclays with 1.65 mln eur for late voting rights disclosures
03:37am, Friday, 27'th Mar 2026
German regulator BaFin said on Friday that it has imposed a fine of 1.65 million euros ($1.9 million) on British bank Barclays for failing to disclose changes to voting rights in
U.S. administration wants a quick deal with Iran: Barclays
11:56pm, Thursday, 26'th Mar 2026
Mitul Kotecha of Barclays sees no signs of an 'obvious off-ramp' between the U.S. and Iran despite the discussions. He says major central banks are turning hawkish, and sees 'pain' for countries who a
ROSEN, A LONGSTANDING LAW FIRM, Encourages Barclays PLC Investors to Inquire About Securities Class Action Investigation - BCS
01:12pm, Thursday, 26'th Mar 2026
New York, New York--(Newsfile Corp. - March 26, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Barcla
Why Barclays Thinks Ionis Is Headed for a 45% Surge From $73 to $106
11:27am, Thursday, 26'th Mar 2026
Ionis Pharmaceuticals (NASDAQ:IONS) has delivered a remarkable 137.52% gain over the past year, though the stock has pulled back 6.12% year-to-date and sits 7.20% below its one-month high, currently t
Barclays sees 13–14 million bpd oil supply loss from prolonged Hormuz disruption
03:26am, Thursday, 26'th Mar 2026
Barclays said on Thursday that a prolonged closure of the Strait of Hormuz would likely lead to a 13-14 million barrels per day supply loss, noting that while the scale of the disruption is immense
Inflation is 'somewhat sticky,' but for nominal earnings, it's not a problem, Barclays exec says
12:30am, Thursday, 26'th Mar 2026
Barclays head of U.S. Equity Strategy & Global Equity Linked Strategies Venu Krishna discusses earnings momentum on 'Making Money.' #fox #media #breakingnews #us #usa #new #news #breaking #foxbusiness
NEW YORK, March 25, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Barclays PLC (NY
Molson Coors Could Drop Another 3% as Barclays Slashes Target to $40 With Underweight Rating
10:22am, Wednesday, 25'th Mar 2026
Molson Coors (NYSE:TAP) has been under sustained pressure heading into 2026.
